William W. Curtis
Chief Executive Officer
William Curtis is Chief Executive Officer of nRichDX and a member of its Board of Directors. William joined nRichDX in July 2015 and brings over 30 years of experience in the healthcare industry. He has exclusively been involved in healthcare business development and healthcare services since 1983.
Prior to joining nRichDX, William was the co-founder, Chairman and Chief Executive Officer of CBLPath Holdings Corporation, a specialized anatomic pathology and molecular laboratory that under his leadership experienced organic, profitable revenue growth from $4MM to $85+MM. Previously, he was the founder and Chief Executive Officer of MLC International and The Hillside Group, healthcare financial and business development companies.
David W. Parker
Chief Financial Officer
David Parker has over 30 years of accounting, finance and business management experience. Prior to nRichDX, he served as contract CFO for an R&D start-up biotechnology company where he was responsible for completing the initial corporate organization as well as the setup of all accounting and reporting functions.
From 2003 through 2014, he was Senior Vice President and Chief Financial Officer of CBLPath Holdings Corporation. CBLPath is a leading provider of sub-specialized anatomic pathology and molecular diagnostic laboratory services. Annual revenues for CBLPath grew from $4MM in 2003 to over $85MM in 2010 when CBLPath was acquired by Sonic HealthCare USA.
Previously, he served as the Vice President of Finance and Administration for The Hillside Group, Vice President of Business Operations for RMS Communications Group, Inc., Vice President and Chief Financial Officer for MFM Industries, Inc., Senior Vice President, Chief Financial Officer and Secretary for Mid-State Federal Savings Bank, and auditor for Deloitte & Touche USA, LLP.
David holds a B.A. in Accounting and Finance from the University of West Florida.
Nafiseh Jafari, PhD
Chief Science Officer
Nafiseh Jafari, PhD is Chief Science Officer at nRichDX. Nafiseh joined nRichDX in January 2020 and has over 10 years experience in life science research. She is a scientific leader with a passion for building and managing high performance teams. Nafiseh has managed multimillion dollar development projects leading to the successful creation and launch of multiple products. Her expertise in talent management and quality/design control systems make her a key member of the nRichDX team.
Immediately prior to joining nRichDX, Nafiseh was a Project Manager leading cross
functional teams at Abbott Diagnostics. She holds a B.S. degree in Chemistry from
Sharif University of Technology and earned her Ph.D. degree in Biochemistry and
Molecular Biology at Western Michigan University.
Senior Vice President Of Marketing & Commercial Operations
Tom Curtis is a life sciences marketing and commercial leader with over 20 years of experience in genomics, biotechnology tools, clinical and molecular diagnostics at industry leaders and start-ups including Human Genome Sciences, OriGene Technologies, QIAGEN, CBLPath, and Sonic Healthcare. He has built successful brands and launched numerous category-leading products, including QIAGEN’s EZ1® and QIAsymphony® nucleic acid extraction platforms, and CBLPath’s ThyroSeq® Thyroid Genomic Classifier. Skilled at building teams and leading people, he excels at strategic and tactical marketing, sales enablement, and commercial operations. Tom has a B.S. degree in Biochemistry from Virginia Tech and graduate education in Marketing from Harvard’s Extension School (HES).
Vice President - Commercial Development
Kamran Syed is Vice President of Sales at nRichDX. Kamran joined the team at nRichDX in January of 2021 and brings over 20 years of commercial experience with roles in Sales, Marketing, Sales Leadership, Business Development and Strategy at a myriad of leading Diagnostics and Life Science companies to include Abbott Laboratories, ThermoFIsher Scientific, Cepheid, Novartis (Genoptix Medical Laboratories), Quest Diagnostics, Cardinal Health, and Illumina. As a Commercial Leader, Kamran has led teams to consistently exceed multimillion dollar revenue and profit targets.
Kamran is a seasoned biotechnology commercial executive that is passionate about and exceptionally skilled in building high performance teams, market development, business development and sales and
strategy execution, helping companies bring to market paradigm shifting molecular diagnostic and
genomic technologies, and high medical value add therapies, which have the potential to transform how patient care is delivered.
Kamran holds a B.S. degree in Biology, with minors in Chemistry and Psychology from Loyola University of Chicago, and an MBA, with a focus in Healthcare Management from the University of Phoenix.
Mayer Saidian, PhD
Vice President - Research & Development
Mayer Saidian, PhD is Vice President of Research & Development for nRichDX.
Mayer joined nRichDX in early 2020 and brings over 15 years of
development experience in molecular biology and life sciences. Mayer is a
scientific leader with passion for breakthrough technologies and combining
cutting edge technologies and bringing them into the scientific and clinical
Prior to joining nRichDX, Mayer was conducting multi-disciplinary and
international research at University of California, Irvine and Hebrew
University in Jerusalem to develop no-invasive methodologies to diagnose
internal diseases, such as diabetes, through the skin. Mayer used advanced
technologies and machine learning skills to perform this study.
Mayer holds B.S. and M.S. degrees in biology and chemistry and earned his
Ph.D. degree in Pharmacology at the Hebrew University in Jerusalem and
University of California, Irvine.